Gastrointestinal Disorders

Clinical Presentation and Diagnosis

• The presence of light-colored stools is a critical clinical sign that should not be overlooked, and serum tumor markers (CA 19-9) may be helpful but have limited sensitivity (40-70%) and specificity (50-80%) in diagnosing biliary obstruction, as stated by the American Gastroenterological Association 1
• Physical examination should look for jaundice, right upper quadrant tenderness, hepatomegaly, or palpable gallbladder, and signs of chronic liver disease in patients with light-colored stools, according to the American Academy of Pediatrics 1, 2
• Liver function tests, complete blood count, coagulation studies, and ultrasound of the liver and biliary tract are essential diagnostic tools for patients with light-colored stools, as recommended by the American College of Gastroenterology 1, 2

Diagnostic Imaging and Testing

• Ultrasound of the liver and biliary tract is the first-line imaging modality, while CT scan or MRI/MRCP may be used for better visualization of the biliary tract in patients with suspected biliary obstruction, as stated by the American Gastroenterological Association 1
• ERCP can be both diagnostic and therapeutic for stone removal or stent placement in patients with biliary obstruction, according to the American Society for Gastrointestinal Endoscopy 1, 2
• The following table summarizes the diagnostic imaging modalities for biliary obstruction:

Management and Treatment

• The American Gastroenterological Association recommends that all patients with persistent light-colored stools should be referred to a gastroenterologist for further evaluation and management, with a strength of evidence supporting early recognition and referral 1
• Infants with jaundice and light-colored stools require urgent referral to a pediatric gastroenterologist for prompt diagnosis and treatment of potential biliary atresia, as recommended by the North American Society for Pediatric Gastroenterology 1, 2
• Surgical intervention, such as the Kasai procedure, is necessary for biliary atresia, as recommended by the Society for Pediatric Surgery 2
• ERCP with stone removal is the treatment of choice for choledocholithiasis, according to the American Society for Gastrointestinal Endoscopy 2
• Stenting for strictures or tumors is a common treatment approach, as stated by the American College of Radiology 2
• Specific therapy for hepatitis or other liver diseases is essential for managing the underlying cause of clay-colored stools, as recommended by the American Association for the Study of Liver Diseases 2

Prevention and Complications

• Prolonged biliary obstruction can lead to fat-soluble vitamin deficiencies (A, D, E, K), potentially causing coagulopathy, and vitamin K supplementation may be necessary in these patients, as stated by the American College of Gastroenterology 1, 2
• Early recognition and referral are crucial in preventing delayed diagnosis and treatment of biliary obstruction and its complications, with a strength of evidence supporting prompt intervention 1, 2
• Hepatitis, cirrhosis, tumors, biliary strictures, and pancreatic cancer can cause biliary obstruction, leading to clay-colored stools, as stated by the American Academy of Pediatrics 2
• The following table summarizes the potential complications of biliary obstruction:

Chronic Diarrhea

• Celiac disease is a chronic autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals, characterized by small intestinal villous atrophy and malabsorption, with a prevalence between 1:200 and 1:559 in European and North American populations, as stated by the American Gastroenterological Association 3, 4
• Tropical sprue occurs in residents of or travelers to tropical regions, characterized by folate and/or vitamin B12 deficiency, and responds to treatment with antibiotics and folic acid, according to the European Society of Clinical Microbiology and Infectious Diseases 5
• Refractory celiac disease is defined as persistent or recurrent malabsorption and diarrhea with villous atrophy despite strict adherence to a gluten-free diet for at least 12 months, and is a rare condition (approximately 1% of celiac disease patients), as stated by the American College of Gastroenterology 3
• The following table summarizes the causes of chronic diarrhea:

Treatment of Chronic Diarrhea

• Strict lifelong gluten-free diet is the primary treatment for celiac disease, with nutritional supplementation as needed, and regular follow-up to monitor adherence and response, as recommended by the American Gastroenterological Association 3
• Treatment for tropical sprue includes tetracycline or doxycycline for 6 months, folic acid supplementation, and vitamin B12 if deficient, according to the European Society of Clinical Microbiology and Infectious Diseases 5
• Treatment for refractory celiac disease includes open-capsule budesonide or prednisone for type 1, and more aggressive treatment, such as azathioprine or infliximab, for type 2, as stated by the American College of Gastroenterology 3
• Targeting the underlying cause of light-colored diarrhea is essential, and may involve bile acid sequestrants, pancreatic enzyme replacement, gluten-free diet, or antibiotics, according to the American College of Gastroenterology 4
• Supportive management, including fluid and electrolyte replacement and nutritional support, is also important, as stated by the American Society of Parenteral and Enteral Nutrition 4